Klaus F. Rabe
Klaus F. Rabe
LungClinic Grosshansdorf
Verified email at - Homepage
Cited by
Cited by
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
KF Rabe, S Hurd, A Anzueto, PJ Barnes, SA Buist, P Calverley, Y Fukuchi, ...
American journal of respiratory and critical care medicine 176 (6), 532-555, 2007
Allergic rhinitis and its impact on asthma (ARIA) 2008
J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ...
Allergy 63, 8-160, 2008
Allergic rhinitis and its impact on asthma
J Bousquet, P Van Cauwenberge, N Khaltaev
Journal of allergy and clinical immunology 108 (5), S147-S334, 2001
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study
KF Rabe, PA Vermeire, JB Soriano, WC Maier
European Respiratory Journal 16 (5), 802-807, 2000
Chronic obstructive pulmonary disease phenotypes: the future of COPD
MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ...
American journal of respiratory and critical care medicine 182 (5), 598-604, 2010
Burden and clinical features of chronic obstructive pulmonary disease (COPD)
RA Pauwels, KF Rabe
The Lancet 364 (9434), 613-620, 2004
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys
KF Rabe, M Adachi, CKW Lai, JB Soriano, PA Vermeire, KB Weiss, ...
Journal of Allergy and Clinical Immunology 114 (1), 40-47, 2004
Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma
M Castro, J Corren, ID Pavord, J Maspero, S Wenzel, KF Rabe, ...
New England Journal of Medicine 378 (26), 2486-2496, 2018
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
PMA Calverley, KF Rabe, UM Goehring, S Kristiansen, LM Fabbri, ...
The Lancet 374 (9691), 685-694, 2009
Outcomes for COPD pharmacological trials: from lung function to biomarkers
M Cazzola, W MacNee, FJ Martinez, KF Rabe, LG Franciosi, PJ Barnes, ...
European respiratory journal 31 (2), 416-469, 2008
Complex chronic comorbidities of COPD
LM Fabbri, F Luppi, B Beghé, KF Rabe
European Respiratory Journal 31 (1), 204-212, 2008
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ...
Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
From COPD to chronic systemic inflammatory syndrome?
LM Fabbri, KF Rabe
The Lancet 370 (9589), 797-799, 2007
Management of non-small-cell lung cancer: recent developments
M Reck, DF Heigener, T Mok, JC Soria, KF Rabe
The Lancet 382 (9893), 709-719, 2013
Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma
KF Rabe, P Nair, G Brusselle, JF Maspero, M Castro, L Sher, H Zhu, ...
New England Journal of Medicine 378 (26), 2475-2485, 2018
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
LM Fabbri, PMA Calverley, JL Izquierdo-Alonso, DS Bundschuh, M Brose, ...
The Lancet 374 (9691), 695-703, 2009
Oral glucocorticoid–sparing effect of benralizumab in severe asthma
P Nair, S Wenzel, KF Rabe, A Bourdin, NL Lugogo, P Kuna, P Barker, ...
New England Journal of Medicine 376 (25), 2448-2458, 2017
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial
JT Annema, JP van Meerbeeck, RC Rintoul, C Dooms, E Deschepper, ...
Jama 304 (20), 2245-2252, 2010
Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial
KF Rabe, ED Bateman, D O'Donnell, S Witte, D Bredenbröker, TD Bethke
The Lancet 366 (9485), 563-571, 2005
The system can't perform the operation now. Try again later.
Articles 1–20